Status:
COMPLETED
Mechanisms of CBD for Chronic Pain
Lead Sponsor:
University of Utah
Conditions:
Chronic Pain
Eligibility:
All Genders
18-50 years
Phase:
EARLY_PHASE1
Brief Summary
This is a study designed to examine the neurochemical mechanisms associated with Cannabidiol (CBD) versus placebo for chronic non-cancer pain.
Detailed Description
The aim of this trial is to examine the neurochemical mechanisms associated with Cannabidiol (CBD) versus placebo for chronic non-cancer pain. Participants will include individuals with chronic pain, ...
Eligibility Criteria
Inclusion
- Age between 18-50 yrs.
- Chronic musculoskeletal and joint pain for at least 3 months or longer.
- Participants must live within a 60 mile radius of Salt Lake City, Utah to be eligible.
Exclusion
- Current or past neurological illness.
- Substance abuse or dependence within the prior 90 days.
- Contraindication to brain MRI.
- Type I and type II diabetes.
- Unstable medical conditions.
- Consumption of more than 2 drinks of alcohol per night.
- Current pregnancy or planning to become pregnant or breastfeeding.
- History of seizures or head trauma at PI discretion.
- Active or history of major mental illness
- Use of opioid medications in the past 30 days.
- LFT results 3 times greater than the upper limit of normal at the screening.
- Participants may be excluded if the PI feels they do not meet safety criteria.
Key Trial Info
Start Date :
March 16 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2024
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT04044729
Start Date
March 16 2020
End Date
December 1 2024
Last Update
April 13 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Of Utah
Salt Lake City, Utah, United States, 84108